What researchers published on Multiple myeloma
3,174 papers, newest first.
Showing 40 of 3,174
Systematic reviewPhysiological prehabilitation for patients undergoing cellular therapy in multiple myeloma and lymphoma: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
In plain wordsRead moreRead the paper on PubMedObservational studyDivergent Cost Trends for 3 Advanced Cancers, 2013 vs 2022: A Commercial Claims Analysis.The American journal of managed care
Case reportMultiorgan [18F]florbetapir PET/CT uptake in multiple myeloma-associated systemic AL amyloidosis: a case report.Medical oncology (Northwood, London, England)
Not labelled yetSpiritual beliefs and preferences among patients with multiple myeloma.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Not labelled yetConstruction and validation of a differential diagnosis model for multiple myeloma and lymphoma based on XGBoost machine learning: an explaining analysis study of SHAP.BMC medical informatics and decision making
Not labelled yetGPRC5D-Directed Antibodies in Multiple Myeloma: New Agents and Frontline Strategies From IMS 2026.Clinical lymphoma, myeloma & leukemia
Not labelled yetModeling Long-Term Progression-Free Survival in Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Not labelled yetGenomic, single-cell, and functional profiling of the CD48-CD244 axis and NK cell dysfunction in multiple myeloma.JCI insight
Not labelled yetSustained measurable residual disease negativity or guaranteed survival time in multiple myeloma?British journal of haematology
Not labelled yetIL-6-driven metabolic reprogramming of the multiple myeloma microenvironment.Cancer & metabolism
Case report[Multiple myeloma with central nervous system involvement successfully treated with a multimodal therapy including elranatamab].[Rinsho ketsueki] The Japanese journal of clinical hematology
Case report[Multiple myeloma presenting with left abducens nerve palsy due to sphenoid sinus plasmacytoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
PreprintGenomic characterization of patient derived xenograft models of multiple myeloma reveals selection of multiple pre-existing high risk clones.bioRxiv : the preprint server for biology
Not labelled yetMultiple Myeloma in a Resource-Limited Setting: Clinical Presentation, Treatment Patterns, and Outcomes From a 99-Patient Cohort in Senegal.EJHaem
Not labelled yetFcRH5-Targeted Therapy in Multiple Myeloma: Evolving Clinical Strategies and Resistance From IMS 2026.Clinical lymphoma, myeloma & leukemia
Not labelled yetDaratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma.Transplantation and cellular therapy
Not labelled yetInfluence of CAR T-cell expansion and persistence in the peripheral blood on CAR T-cell therapy efficacy and adverse events in multiple myeloma.Bone marrow transplantation
Case reportUndetected Intracellular Immunoglobulin Light Chains in Aberrant Plasma Cells of Multiple Myeloma by Monoclonal Antibody-Based Flow Cytometry: A Question Raised by a Single Case.Journal of immunology research
ReviewBridging Innovation in Multiple Myeloma Care: A Review of Novel Therapies.Journal of the advanced practitioner in oncology
ReviewEarly Treatment Failure in Real-World Bispecific-Antibody Therapy for Relapsed or Refractory Multiple Myeloma: Pathways, Determinants, and Measurement Gaps.OncoTargets and therapy
Not labelled yetPrognostic significance of IgG-Kappa positivity detected by serum immunofixation during daratumumab therapy in multiple myeloma.Upsala journal of medical sciences
Case reportEpithelioid Angiosarcoma Masquerading as Multiple Myeloma: A Diagnostic Pitfall.Cureus
Not labelled yetCDK4/6i reverses MEIS2 inhibition of CRL4CRBN and promotes BCMA loss to enhance IMiD/CELMoD therapy in multiple myeloma.Blood neoplasia
Not labelled yetSociety for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of multiple myeloma, version 2.0.Journal for immunotherapy of cancer
Not labelled yetOrthopnea From Phrenic Nerve Palsy After Ciltacabtagene Autoleucel CAR T-Cell Therapy in a Patient With Multiple Myeloma.Journal of the advanced practitioner in oncology
Not labelled yetIntegrating biology, frailty, and patient values: The 5M framework for older adults with multiple myeloma.Clinical hematology international
PreprintComputational alternative to cardiac biopsy in multiple myeloma: utilizing the shape of routine laboratory data for the classification of AL cardiac amyloidosis.bioRxiv : the preprint server for biology
Not labelled yetSuccinate promotes multiple myeloma cell proliferation through TCA cycle oxidation.Cell reports
ReviewCombination antiviral treatment for a patient with lymphocytic choriomeningitis virus meningoencephalitis associated with bispecific antibody teclistamab therapy for myeloma.The Lancet. Infectious diseases
Case reportLenalidomide-associated B-cell acute lymphoblastic leukemia in a multiple myeloma patient: a case report.Journal of medical case reports
ReviewPractical Recommendations for Implementing Remote Patient Monitoring for Patients Receiving Bispecific Antibodies for Multiple Myeloma.JMIR cancer
Not labelled yetAI-Driven Structural Analysis Clarifies Novel TNFRSF17 Variants of Uncertain Significance as Candidate Resistance Mechanisms to BCMA-Targeted Immunotherapies in Multiple Myeloma.Clinical lymphoma, myeloma & leukemia
Not labelled yetStatement of Retraction: A novel circRNA-miRNA-mRNA network revealed exosomal circ-ATP10A as a biomarker for multiple myeloma angiogenesis.Bioengineered
Case report[Personalized Dosing of Lenalidomide Based on Integrated Assessment of Renal Function and Frailty in Multiple Myeloma].Gan to kagaku ryoho. Cancer & chemotherapy
Not labelled yetDynamic biomarkers of kidney function in patients with newly diagnosed multiple myeloma receiving daratumumab-based combination therapy.British journal of haematology
Not labelled yetThe impact of pomalidomide-containing induction on stem cell mobilization and engraftment in multiple myeloma: a single-center experience.Annals of hematology
Not labelled yetMachine-Learning-Guided Identification of CCT245737 as a Functional Pan-G-Quadruplex Ligand for the Treatment of Multiple Myeloma.The journal of physical chemistry. B
Not labelled yetIncreased Overall Survival for Subcutaneous Versus Intravenous Daratumumab in Medicare Beneficiaries With Multiple Myeloma.Clinical lymphoma, myeloma & leukemia
Not labelled yetAn Open-label, Multicenter, Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) in Combination with Propranolol and G-CSF for the Mobilization of Hematopoietic Progenitor Cells in Multiple Myeloma Patients.Transplantation and cellular therapy
Not labelled yetImpact of granulocyte colony-stimulating factors on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma.Blood cancer journal